Position in AZN
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$447,881,295
New position
Shares Held
2,270,973
first reported quarter
Ownership
0.146%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026ENVESTNET ASSET MANAGEMENT INC holds $6,287,172,439 across 16 Drug Manufacturers - General names. AZN ranks #6 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,942,508 | $1,208,146,655 | |
| 2 | LLY |
ELI LILLY & Co
|
1,175,177 | $1,080,892,549 | |
| 3 | ABBV |
AbbVie Inc.
|
4,853,567 | $1,055,602,286 | |
| 4 | AMGN |
Amgen Inc
|
1,697,306 | $597,197,116 | |
| 5 | MRK |
Merck & Co., Inc.
|
3,852,976 | $463,474,483 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
2,270,973 | $447,881,295 | |
| 7 | NVS |
Novartis AG
|
2,311,384 | $353,063,906 | |
| 8 | PFE |
Pfizer Inc
|
9,345,601 | $262,424,476 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $447,881,295 | 2,270,973 | Shares | Sole | 2026-05-04 | |
| No filing history on record for this holder in this stock. | ||||||